" class="no-js "lang="en-US"> MyndVR and AgeWell New York Partner for Health Care Coverage
Friday, May 17, 2024

MyndVR Partners with AgeWell New York for First Health Care Coverage Plan

MyndVR, the award-winning provider of VR-based, digital therapeutic experiences designed for the aging population, has announced a new partnership with AgeWell New York. A pioneering partnership for MyndVR, AgeWell New York’s CareWell members will now have access to MyndVR’s virtual reality therapy sessions.

AgeWell New York is a specialty managed care organization serving Medicare and Medicaid populations in the New York metropolitan area, including the Bronx, New York (Manhattan), Queens, Kings (Brooklyn), Nassau, Westchester, and Suffolk counties. As of January 1, CareWell plan members have access to virtual reality alternative therapies.

“Our members are enthusiastic about their ability to use MyndVR,” said Agewell New York Lead Senior Benefits Advisor, Constance Harris-Fields. “We see this program helping with isolation, anxiety, and depression, while stimulating memories, conversation, and socialization, which is especially important in the wake of the pandemic.” AgeWell New York’s CareWell Plan members can use MyndVR headsets to enjoy virtual travel, special adventures, entertainment and more. They can also share their experience in real time with family members near and far. “We’ve seen first-hand how visiting a special place can brighten the outlook of our skilled nursing facility members. The MyndVR benefit enhances our personalized approach to health care.”

“It is monumental to our mission to bring on board our first health insurance provider, to help broaden access to the impactful results of MyndVR to CareWell members,” said MyndVR CEO and Founder, Chris Brickler. “As we continue spreading awareness of the importance of therapeutics in VR being covered by insurance, this is an exciting step in the right direction – only further proving why the Access to Prescriptive Digital Therapeutics Act has a growing need to be passed by Congress.”

The partnership marks a major milestone for MyndVR as the company looks to expand coverage of its groundbreaking technology amongst Medicare Advantage plans and Managed Medicaid plans. The company also recently announced its DitigalTherapyNow.org coalition in support of the Access to Prescription Digital Therapeutics Act, which would formally recognize digital therapeutics at a federal level. The coalition provides information, updates, resources, and a growing petition to support the successful passing of the bill.

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more